The Institute for Healthcare Improvement (IHI), an independent not-for-profit organization based in Boston, Massachusetts, is a leading innovator, convener, partner, and driver of results in health and health care improvement worldwide. At our core, we believe everyone should get the best care and health possible. This passionate belief fuels our mission to improve health and health care.
Episodes
Friday Aug 10, 2018
Friday Aug 10, 2018
August 2005 Author in the Room® Teleconference
Authors: Judith Ockene, PhD, MEd, and David H. Barad, MD, MS
Article: "Symptom Experience After Discontinuing Use of Estrogen Plus Progestin"
Summary Points:
- Of the women who stopped estrogen plus progestin (E+P), 21.2 percent had menopausal symptoms (hot flashes or night sweats) after stopping study medication compared to 4.8 percent of women who were on placebo.
- Of the women who had menopausal symptoms when they started the study (about 12 percent) and were in the active hormone group, over 50 percent had a recurrence of symptoms after they stopped MHT compared to 21 percent of placebo users who had a recurrence of symptoms.
- Women in the E+P group reported higher rates of pain or stiffness (36.8 percent) after they stopped study medication compared to women who had been on placebo (22.2 percent).
- Women who had symptoms after they stopped study medication reported using a wide range of strategies to manage symptoms and a large proportion found the strategies to be helpful.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.